Saturday 17 October 2026 Export HRTX’s income statement to Excel — free account

Heron Therapeutics, Inc.

Heron Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $154.9 million, up 7.36% from fiscal 2024. In the quarter to June 2026, revenue grew 1.25%, EPS fell 93.6%, free cash flow grew 78.8% and total debt fell 18.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

0.36 0.02 −5.26%

Follow HRTX

Alert me

Market cap: $71.5M
P/E: 0.0×
Fwd P/E: −6.6×
Dividend yield: —
F-score: 4/9
Altman Z: −8.84
Beneish M: −2.40
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		1.38	1.40	1.01	0.54
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		161.26	(23.60)	(98.52)	(36.98)
P/B ratio Full definition →		30.56	16.32	18.76	13.97
Price to Tangible BV Full definition →		30.56	16.32	18.76	13.97
EV/Sales Full definition →		1.93	2.01	1.65	1.20
EV/EBITDA Full definition →		78.04	0.00	0.00	0.00
EV/Operating CF Full definition →		(9.90)	(11.26)	(12.27)	(15.67)
EV/FCF Full definition →		(9.63)	(11.17)	(11.95)	(15.04)
Quick Ratio Full definition →		1.52	1.42	1.42	1.44
Current Ratio Full definition →		2.56	2.48	2.53	2.49
Net Debt/EBITDA Full definition →		(24.67)	136.24	(23.28)	(65.95)
Debt/Assets Full definition →		56.10%	54.96%	57.52%	56.55%
Debt/Equity Full definition →		9.38	9.81	15.50	20.65
Asset Turnover Full definition →		0.66	0.63	0.63	0.62
Operating CF/Net income Full definition →		(0.08)	3.11	0.19	0.40
Capex/Depreciation Full definition →		0.04	0.02	(0.65)	(0.26)
Research and Development Expense of Revenue Full definition →		9.08%	9.23%	6.87%	7.17%
Selling, General and Administrative Expense of Revenue Full definition →		70.45%	63.28%	76.21%	67.53%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		7.46%	5.37%	8.57%	8.44%
Graham Net Nets Full definition →		(0.02)	(0.02)	(0.05)	(0.19)
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(5.99%)	(8.88%)	(21.94%)	(44.19%)
Free Cash Flow Yield Full definition →		(14.46%)	(12.83%)	(13.71%)	(14.77%)
Revenue per Share Full definition →		0.22	0.24	0.18	0.20
Operating CF per Share Full definition →		0.01	(0.06)	(0.01)	(0.01)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.01	(0.05)	(0.01)	(0.01)
Cash per Share Full definition →		0.33	0.28	0.24	0.22
Shareholders Equity per Share Full definition →		0.09	0.09	0.05	0.04
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		0.09	0.09	0.05	0.04
Free Cash Flow Full definition →		1.36	(9.17)	(1.93)	(2.35)
Working Capital Full definition →		139.69	141.97	138.47	137.70
Capital Expenditures Full definition →		0.03	0.02	(0.39)	(0.14)
Net Current Asset Value Full definition →		(4.66)	(3.48)	(8.09)	(15.51)
EV/EBIT Full definition →		187.11	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.01	0.00
Price to Operating Income Full definition →		134.40	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		74.04	84.23	81.21	84.75
Average Payables Full definition →		11.10	10.35	10.65	11.84
Average Inventory Full definition →		57.99	72.95	74.74	81.78
Average Assets Full definition →		234.86	244.51	240.98	242.18
Average Common Equity Full definition →		(16.49)	(10.18)	(10.18)	(10.70)

Show all line items

Columns are period end dates

Stockrow Weekly